logo

For the Inventor, By the Inventor

Ageo, Japan

Yasushi Honma

This inventor holds 9 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1982-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasushi Honma. Retrieved from https://idiyas.com/inventor/yasushi-honma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal9 out of 324 
 
Tanabe Seiyaku Company, Limited
 patents

Years Active: 1982-1996

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5510354 - Imidazopyridine derivatives (1996-04-23),
2. 5424316 - Imidazopyridine derivatives for the treatment of hypertension (1995-06-13),
3. 5409936 - Imidazopyridine derivatives for the treatment of hypertension (1995-04-25),
4. 5268377 - Imidazoindolizine derivatives process for preparation thereof and use (1993-12-07),
5. 5053417 - Imidazole derivatives and preparation thereof (1991-10-01),
6. 5002945 - Imidazole derivatives (1991-03-26),
7. 4996217 - Pyridyl-substituted imidazoles, compositions containing same and methods (1991-02-26),
8. 4404214 - 2-Pyridinecarboxamide derivatives compositions containing same and (1983-09-13),
9. 4332809 - Pyridinecarboxamide derivatives and process for the preparation thereof (1982-06-01),

Title: Yasushi Honma: Innovator in Hypertension Treatment

Introduction

Yasushi Honma is a prominent inventor based in Ageo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for the treatment of hypertension. With a total of 9 patents to his name, Honma's work has had a substantial impact on medical science.

Latest Patents

Honma's latest patents include innovative imidazopyridine derivatives. One of his notable inventions is an imidazopyridine derivative of formula I, where R¹ is lower alkyl, R² is a specific group, Z is oxygen, and R⁰ is a pyridyl, furyl, or thienyl group. This compound is designed for use in the prophylaxis and treatment of hypertension. Another significant patent involves an imidazopyridine derivative that is useful in the same medical context, featuring various functional groups that enhance its efficacy.

Career Highlights

Yasushi Honma is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new treatments that can improve patient outcomes in hypertension management.

Collaborations

Honma has collaborated with esteemed colleagues such as Yasuo Sekine and Sumihiro Nomura. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Yasushi Honma's contributions to hypertension treatment through his innovative patents highlight his role as a key figure in pharmaceutical research. His ongoing work promises to advance medical science and improve health outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…